JP Patent

JP2783722B2 — スピカマイシン誘導体およびそれを含む抗腫瘍剤

Assigned to Kirin Brewery Co Ltd · Expires 1998-08-06 · 28y expired

What this patent protects

Patent listed against dalbavancin-hydrochloride.

Drugs covered by this patent

dalbavancin-hydrochloride (DALBAVANCIN HYDROCHLORIDE)

Patent Metadata

Patent number: JP2783722B2
Jurisdiction: JP
Classification: —
Expires: 1998-08-06
Drug substance claim: No
Drug product claim: No
Assignee: Kirin Brewery Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.